Malaysia to test Cuban cancer vaccine
|
| Published on Friday, March 30, 2007 |
Email To Friend Print Version |
HAVANA, Cuba (ACN): Malaysia's Bioven biotechnological center will start tests on a Cuban vaccine against Cancer, which has sparked great expectations in that Asian country.
The Malaysian daily New Straits Times referred on Thursday to the Cuban vaccine, developed by the island's Molecular Immunology Center (CIMC), as an antidote that offers patients with terminal cancer new hopes to keep living.
The Bioven center will carry out tests on the vaccine with the cooperation of the Clinical Research Institute at Kuala Lumpur's Hospital and the assistance and supervision of Cuban doctor Gisela Gonzalez, a CIMC expert.
This will be the first major clinical test with a biotechnological compound ever carried out in the southeast Asian country, News Straits daily reported.
The tests will include 230 patients suffering from advanced lung cancer in all the country's hospitals. They will be administered the Cuban vaccine, known by the acronym FCE, once a month.
Gonzalez explained that the vaccine provokes an immunological action by the human body which stops the growth of cancer cells and destroys those already infected; however, she said the FCE is not an absolute solution to cancer, though it contributes to stop its growth and spread within the human body.
Previous tests in Cuba, Canada and Britain proved that the Cuban vaccine may double the expectancy of life of cancer patients, the expert explained.
The Cuban vaccine can be used to fight 60 percent of all types of cancer including lung, breast, bladder, brain, neck, prostate and others. | | | | Reads : 278 | | | |
|
|
